Secretary General Wang Rui of Health Growth Society: Breaking the Information Silos in the Out-of-Hospital Market to Efficiently Match Premium Products with Emerging Channels [2025 VBEF]
Driven by deepening healthcare reforms and policy incentives, China’s pharmaceutical industry is undergoing a structural shift from a “hospital-centric” model to one characterized by “collaboration between in-hospital and out-of-hospital settings.” Traditional channels are struggling in a saturated market, high-quality products are seeking new avenues for growth, data silos are fragmenting supply and demand, and inefficient matching is eroding growth potential. Both pharmaceutical manufacturers and medical device companies are accelerating their expansion into the out-of-hospital market in pursuit of incremental breakthroughs.
On May 9, 2025, the founding ceremony of the Health Growth Society was successfully held at the main forum of the 2025 VBEF Top 100 Future Healthcare and Pharmaceuticals Exhibition, hosted at the Suzhou International Expo Center. The event featured the participation of Wang Rui, Secretary-General of the Health Growth Society; Li Datao, Founder of VCBeat; Yu Rong, Chairman of Meinian Onehealth Healthcare Group and Chairman of the Health Growth Society; and Fan Jing, Head of Digital Marketing, Pharmaceutical Business Division, JD Health. During the ceremony, Mr. Li Datao, Founder of VCBeat, and Ms. Wang Rui, Secretary-General of the Health Growth Society, presented the official plaque to Mr. Yu Rong, Chairman of Meinian Onehealth Healthcare Group, in his capacity as Chairman of the Health Growth Society.
Health Growth Society Officially Established
From left to right: Wang Rui, Secretary-General of the Health Growth Society; Li Datao, Founder of VCBeat; Yu Rong, Chairman of Meinian Onehealth Healthcare Group and Chairman of the Health Growth Society; Fan Jing, Head of the Digital Marketing Department, Pharmaceutical Business Division, JD Health.
Health Growth Society adheres to the mission of “Precise Connection, Knowledge Empowerment, and Ecosystem Collaboration.” With a core focus on out-of-hospital commercial growth needs, it bridges the link between “Production (pharmaceutical companies/medical devices/health products)” and “Sales (new channels),” thereby building an out-of-hospital market ecosystem community driven by new products, new production models, and new channels. This enables efficient matching between the most outstanding product providers in the pharmaceutical and healthcare industry and the leading new-channel players, jointly creating China’s largest commercial growth transaction platform for the medical and healthcare sector.
Plaque Awarding Ceremony for the Chairman of the Health Growth Society
From left to right: Li Datao, Founder of VCBeat; Yu Rong, Chairman of Meinian Onehealth Healthcare Group and Chairman of the Health Growth Society; Wang Rui, Secretary-General of the Health Growth Society.
On the morning of May 10, at the Conference on New Product and New Channel Growth in the Out-of-Hospital Market, held as part of the Top 100 Future Healthcare and Pharmaceuticals Exhibition, Wang Rui, Secretary-General of the Health Growth Society, delivered an insightful presentation themed “The Long-Termism of the Health Growth Society: A New Growth Curve for the Medical and Healthcare Industry.”
Wang Rui, Secretary-General of the Health Growth Society
Currently, growth in the in-hospital market is sluggish, with shrinking revenues and significant pressure. The traditional hospital-centric, single-channel marketing model has hit a structural bottleneck. In this context, the coordinated development of “in-hospital + out-of-hospital” operations has become an irreversible direction for industry transformation, driving a systematic restructuring of business models, marketing strategies, and product strategies.
Three key dimensions corroborate this trend: First, from the perspective of the healthcare industry, the out-of-hospital market is undergoing structural expansion—its channels, including offline pharmacy chains, online internet platforms, and O2O services, already account for one-third of the total market share. Industry forecasts predict that by 2029, the out-of-hospital market share will surpass that of the in-hospital market for the first time. Second, consumer-side data further validates this trend. For instance, on Xiaohongshu (Little Red Book), search volume and the number of posts in the health category have seen significant growth, with the platform’s health-related user base exceeding 150 million. Third, the post-pandemic era has witnessed the widespread adoption of holistic health concepts and an upgrade in health-related demands.
However, severe information asymmetry in the out-of-hospital market has left many high-quality products hidden “underwater,” relying solely on industry connections for recommendation due to a lack of effective screening criteria and promotional channels. Meanwhile, fragmented channel resources have prevented professional operational talent and distribution networks from achieving synergistic effects, making it difficult to effectively match supply with demand.
In response to the aforementioned pain points, the Health Growth Society was established. Guided by its Council and operated by its Secretariat, this industry organization fosters collaborative participation from two types of member units—Product Members and Channel Members. It aims to serve as a “super connector” in the out-of-hospital market by precisely linking corporate decision-makers, growth strategy experts, and channel operators. Through the systematic integration of product, channel, and operational resources, it breaks down industry information silos and resolves resource mismatches, enabling efficient alignment between high-quality products and emerging channels. Ultimately, it empowers enterprises to achieve sustainable commercial value conversion and promotes high-quality industry development.
Specifically, the Health Growth Society empowers its corporate members through two core value systems. The first is the “Smart Chain” system, which breaks down information silos in the out-of-hospital market, enabling high-quality products to connect directly with new channels and streamline the “production-to-sales” pipeline. By deconstructing industry benchmark cases and curating product selection and channel strategies, this system helps enterprises master core strategies for new channel layout, new user outreach, and iterative innovation in go-to-market approaches. The second is the “Symbiosis” system, which builds a community of shared destiny within the out-of-hospital ecosystem. Leveraging platform resources, it assists high-quality enterprises in accessing financing channels, achieving genuine growth in product sales, and supporting their long-term development.
It is reported that the Health Growth Society will launch four targeted IP initiatives in 2025. These include hosting the China Healthcare Commercial Growth Summit Forum and the First New Channel Trade Exhibition, selecting exemplary cases of commercial growth in China’s healthcare sector, and publishing the inaugural white paper on commercial growth in the out-of-hospital market based on these selections. Additionally, the society will organize small-scale, practical workshops and private board meetings to analyze case studies focused on out-of-hospital market growth, as well as implement an elite training program for enterprises involved in this sector. These efforts aim to provide genuine empowerment and support for new products and new channels.
Among these initiatives, the Commercial Growth Case Study Practical Workshop by the Health Growth Society targets founders of leading enterprises. By inviting industry luminaries to deconstruct the top-level strategy and practical implementation pathways for blockbuster products, it provides a step-by-step guide covering everything from product analysis to on-the-ground execution. The Commercial Growth Elite Program, meanwhile, is more enterprise-focused. It deploys founder-level mentors into companies to conduct in-house training, working closely with member enterprises to identify and resolve growth bottlenecks at the intersection of “channels × products × users,” thereby providing genuine empowerment and support for new products and new channels. Looking back at 2024, the market saw the emergence of several benchmark cases, such as an OTC product that achieved explosive growth from a small-scale operation to a billion-yuan blockbuster through a combined “online + private domain” strategy. During the current window of expansion in the out-of-hospital market, more such blockbuster products are expected to emerge. The top-level design behind their success is precisely what Growth Secret Room aims to reveal.
Leveraging its unique mechanistic advantages and innovative ecosystem, the out-of-hospital market is gradually becoming a value amplifier for high-quality assets in China’s healthcare and pharmaceutical sector, and is poised to enter a phase of breakthrough growth. Health Growth Society looks forward to forging an intelligent, symbiotic partnership with premium products and robust distribution channels to achieve sustainable commercial growth and jointly create a new growth curve for the healthcare industry.